Page 89 - 2024 Taiwan Health and Welfare Report
P. 89

06 | Communicable Disease Control








                       the self-health management period was reduced   cases based on severity. Cumulatively, nearly
                       from 10 to 5 days on August 15, 2023. Mask      130,000 individuals were admitted.
                       regulations were relaxed, with mandatory mask   (3)  To further increase the country's testing capacity,
                       wearing remaining effective in hospitals, clinics,   the MOHW expanded a nationwide network
                       general nursing homes, and elderly welfare      of 268 designated testing institutions with a
                       institutions. Other medical institutions changed   maximum daily testing of 238,781 specimens as
                       to recommend mask-wearing.                      of 2023.
                    (2)  Vaccine Preparation and Vaccination        (4)  Researched and evaluated SARS-CoV-2
                       To obtain safe and effective vaccines, Taiwan   detection methods and reagents, including virus
                       pursued both international procurement and      culture, nucleic acid, antigen, and antibody tests.
                       domestic development. A cumulative total of     Developed and transferred the technology of
                       68.41 million COVID-19 vaccine doses were       SARS-CoV-2 antibody and antigen diagnostic
                       procured, including about 4.76 million doses    reagents to  assist  in  the  development of
                       through COVAX, 10 million doses of AstraZeneca,   domestic testing reagents. Viral strains were sent
                       41.05 million doses of Moderna, 7.6 million doses   to relevant institutions to facilitate the operation
                       of BNT, and 5 million doses of domestic vaccines.  of the "COVID-19 viral screening and analysis
                       To achieve stable reopening and return to normal   support platform" to support research and
                       life, a "2023 National COVID-19 Vaccination     development in academia, industry, and research
                       Campaign" was launched from March 6             institutions.
                       to April 30, 2023. The "Vaccine Plus One.   5. Disseminating Information and Uncovering
                       Easing Restriction Safely." campaign was also   Disinformation
                       implemented to encourage the bivalent vaccine   (1)  From the establishment of the CECC until the
                       uptake. From March 22, 2021, to September 30,   end of 2023, a total of 960 press conferences
                       2023, approximately 68.16 million doses of the   were held, issue 2,199  press releases,
                       original and bivalent vaccines were administered.
                                                                       50 clarifications, 84 letters to the medical
                       In response to COVID-19 virus mutations and     community, and producing 7,001 educational
                       to enhance immunity against dominant strains,   leaflets on key topics. These were used to
                       XBB vaccines were offered from September 26,     release important epidemic information, policies,
                       2023. By December 31, 2023, about 965,000       and measures to the public. Additionally,
                       XBB vaccine doses had been administered, with   educational videos for epidemic prevention
                       a national coverage rate of 3.64%.              were produced and translated into multiple
                  4. Medical Response and  Medical Supplies            foreign languages. Various media platforms,
                    Preparedness                                       including broadcasting, online media, and the
                    (1)  Continued to adapt to changes in the epidemic,   public warning service, were expropriated and
                       continually refining infection control measures   utilized to disseminate real-time and transparent
                       in healthcare facilities and laboratory biosafety   domestic and international epidemic information,
                       policies, preparing contingency strategies      as well as various epidemic prevention decisions
                       and guidelines, gradually easing COVID-19       and measures.
                       prevention measures, and returning to normal   (2)  Taiwan CDC expanded the capacity of its
                       management of healthcare facilities.            "1922 Hotline," and additional features such
                    (2)  Continued to establish government quarantine   as automated SMS replies and voice message
                       facilities to accommodate individuals undergoing   capabilities were introduced to ensure efficient
                       isolation / quarantine, as well as mild cases   call diversion. These measures aimed to ensure
                       in accordance with the CECC's principle for     that inquiring individuals could promptly access
                       admitting and treating confirmed COVID-19       the information they needed. When the Central




                                                                                                                  87
   84   85   86   87   88   89   90   91   92   93   94